In Depth Analysis on Medical Marijuana Market| Top Players: Canopy Growth Corporation, Aphria, Aurora Cannabis Inc., GW Pharmaceuticals plc

Research on marijuana's potential for medicinal use is on an upsurge in various parts of the world. In February 2018, WeedMD, a licensed Canadian medical marijuana producer, announced its partnership with the cannabis database project controlled by the Technion-Israel Institute of Technology (TIT). The collaborative entity would research cannabinoid and terpenoid profiles of 25 of WeedMD’s cannabis strains. Similarly, in 2017, Oxford University announced its partnership with private equity company, Kingsley Capital Partners, for developing novel cannabis treatments for pain, cancer and inflammatory diseases. These research studies will result in number of product approvals for various medical conditions and hence have a positive impact on the medical marijuana market growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2836

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Canopy Growth Corporation
• Aphria
• Aurora Cannabis Inc.
• GW Pharmaceuticals plc
• Medical Marijuana, Inc.
• United Cannabis Corporation
• MedReleaf
• The Supreme Cannabis Company
• CanniMed Ltd.
• Tilray
• Emerald Health Therapeutics Inc.
• Cannabis Sativa Inc
• Insys Therapeutics, Inc.
• Corbus Pharmaceuticals
• Namaste Technologies

Medical marijuana pain management market held around 75% share of total application market valuation, accounting for a total value of USD 5,481.1 million 2017. Being one of the biggest health problems, Chronic pain management using marijuana happens to be its largest application area. According to past research studies, 1 in 10 adults are diagnosed with chronic pain each year; with increasing success from marijuana in pain management, the demand for the same should increase multi-folds during the forecast period. Neuropathic pain captured the largest market share in 2017 due to increased number of peripheral neuropathy cases. Also, marijuana being an effective treatment for neuropathic pain, its use will further rise over the forecast timeframe.

The medical marijuana market for skin-related conditions such as eczema and psoriasis, is estimated to show lucrative growth in near future; in fact, is estimated to expand at 37.4% CAGR from 2018-2024. Various research studies have shown that cannabinoids, one of the active ingredients of marijuana, may help regulate inflammation and immune function, hence increasing their application in due course of time. Millions of people affected with serious skin diseases should prove to be a potentially massive target market in near future.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2836

U.S. medical marijuana market valued USD 3,549.0 million in 2017 and will grow multi-folds in near future owing to increasing medical marijuana applications. As of 2018, 30 U.S. states and Washington DC have allowed the application of medical marijuana. Also, growing number of research studies in the US, supporting marijuana's use for medical purposes should supplement the North American medical marijuana market growth.

Medical Marijuana Market by Application
• Pain Management
• Neuropathic Pain
• Cancer Pain
• Others
• Muscle Spasms
• Nausea
• Anorexia
• Seizures

Medical Marijuana Market by Route of Administration
• Inhalation
• Oral
• Topical

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.